ICCM

IceCure Medical Ltd.

1.01 USD

Last updated Dec 4, 20:41 UTC

Yesterday HIGH

$1.15

Yesterday LOW

$1.01

52w HIGH

$4.73

52w LOW

$0.52

EPS

-0.168

PE

-6.01

Next Earnings

Aug 14, 2023

Overview News Government Trades

IceCure Medical Ltd. stock is up 32.89% since 30 days ago. The next earnings date is Aug 14, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 4 December’s closed higher than November. 100% of analysts rate it a buy.

IceCure Medical Ltd engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Medical Equipment

Headquarters

-

Website

icecure-medical.com

Benzinga Newsdesk

Mon Oct 2, 2023

Independent Study Validates IceCure's ProSense Cryoablation Is Safe & Effective Outpatient Procedure For Breast Cancer With 96.8% Success Rate

Study was conducted in Spain with women who declined standard of care surgeryProSense is approved for the treatment of breast cancer throughout the European UnionCAESAREA, Israel, Oct. 2, 2023 /PRNewswire/ -- IceCure
Lisa Levin

Wed Sep 20, 2023

Gold Moves Higher; Fed Leaves Key Overnight Interest Rate Unchanged

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 200 points on Wednesday. The Dow traded up 0.59% to 34,720.69 while the NASDAQ fell 0.07% to 13,668.37. The S&P 500 also rose, gaining, 0.17% to 4,451.42.
Lisa Levin

Wed Sep 20, 2023

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.
Lisa Levin

Wed Sep 20, 2023

Nasdaq Turns Lower; Cambridge Bancorp Shares Surge

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Wednesday. The Dow traded up 0.56% to 34,711.50 while the NASDAQ fell 0.17% to 13,654.54. The S&P 500 also rose, gaining, 0.21% to 4,453.12.
Vandana Singh

Wed Sep 20, 2023

Why Is Medical Device Firm IceCure Medical Stock Trading Lower Today?

The FDA has denied IceCure Medical Ltd's (NASDAQ: ICCM) De Novo Classification request for the ProSense System for breast cancer, which was submitted based on interim
Benzinga Newsdesk

Wed Sep 20, 2023

IceCure Medical Says FDA Has At This Time Denied Its De Novo Classification Request For Breast Cancer Which Was Submitted Based On Interim Analysis From Its ICE3 Study
Benzinga Insights

Wed Sep 6, 2023

Expert Ratings for Icecure Medical
Benzinga Newsdesk

Wed Sep 6, 2023

HC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $3 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $3 price target.
Happy Mohamed

Tue Sep 5, 2023

IceCure Medical's ProSense Cryoablation System Receives Regulatory Approval In Brazil; $6.6M In Sales Expected In Brazilian Market Over The Next Five Years Per Distribution Agreement Guarantees

$6.6 million in sales expected in Brazilian market over the next five years per distribution agreement guarantees High level of early interest in ProSense in South America's largest
Happy Mohamed

Mon Aug 28, 2023

IceCure Medical Takes Next Major Initiative As It Prepares To Accelerate The Commercialization Of ProSense In U.S. And Canada: Appoints VP Of Sales, North America

Mr. Shad Good brings nearly 20 years of medical device sales and leadership experience, including as U.S. Senior Director of Sales at a global leader in minimally invasive breast diagnostic and therapeutic